NIH awards $12M for development of antiviral therapies The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), has awarded three institutions more than $12 million for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.Read More
Unusual antibody proves potent against Zika virus Researchers have identified an unusual type of antibody that, even at miniscule levels, neutralizes the Zika virus rendering viral infection undetectable in preclinical models.Read More
Scientists regenerate severed axons in mice Researchers out of Hong Kong have regenerated severed axons by deleting a specific gene and combining it with an interferon, which has implications for central nervous system damage.Read More
New prodrug eliminates cancer cells without harming healthy cells Johns Hopkins Medicine researchers have revamped an anticancer drug to preferentially eliminate cancer cells while leaving healthy cells unharmed. The study, published November 16 in the journal Science Advances, utilized a prodrug designed to release its payload into a tumor.Read More
NSF grant awarded to develop membrane purification platform University of Kentucky researchers, in collaboration with the University of Arkansas and Clemson University, have received a $1.6 million National Science Foundation (NSF) grant to create a membrane purification platform for large-scale biomanufacturing of viral vectors and virus-like particles.Read More